2007
DOI: 10.1007/s00109-007-0243-9
|View full text |Cite
|
Sign up to set email alerts
|

Thymosin β4 and Ac-SDKP: Tools to mend a broken heart

Abstract: Thymosin beta4 - an endogenously occurring 43 amino acid peptide - has recently been shown to possess cardioprotective properties in the setting of acute myocardial infarction. This review focuses on the reported mechanisms of action through which Thymosin beta4 might accomplish this effect and the clinical prospects for its use as a therapeutic agent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0
1

Year Published

2009
2009
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(25 citation statements)
references
References 47 publications
0
24
0
1
Order By: Relevance
“…The Ac-SDKP peptide has been implicated in a number of biological processes, including fibrosis, proliferation, and angiogenesis (5355). While thymosin β4 is expressed in the brain, the Ac-SDKP peptide has mostly been studied in the periphery, specifically the cardiovascular system.…”
Section: Discussionmentioning
confidence: 99%
“…The Ac-SDKP peptide has been implicated in a number of biological processes, including fibrosis, proliferation, and angiogenesis (5355). While thymosin β4 is expressed in the brain, the Ac-SDKP peptide has mostly been studied in the periphery, specifically the cardiovascular system.…”
Section: Discussionmentioning
confidence: 99%
“…47 ACE is the major peptidase that acts to degrade Ac-SDKP; 48 after acute ACE inhibition, plasma levels of Ac-SDKP increase by approximately five-fold in of AT1 receptor signaling appear deviant in their developmental patterns of cytokine expression. These studies have to be viewed with caution since the studies used GM-CSF induced dendritic cells, which may not represent the diversified populations of dendritic cells in vivo.…”
Section: Ac-sdkpmentioning
confidence: 99%
“…Ac-SDKP is derived from the 43 amino acid peptide thymosin β4 (Tβ4) which has cardioprotective properties in acute myocardial infarction [47]. It was proposed that some of the therapeutically beneficial effects of Tβ4 may be due to action of Ac-SDKP [47].…”
Section: Hypothesis Of An Imbalance Between the Inhibition And Activamentioning
confidence: 99%
“…It was proposed that some of the therapeutically beneficial effects of Tβ4 may be due to action of Ac-SDKP [47]. Since intrapericardially administered fibroblast growth factor of mol.…”
Section: Hypothesis Of An Imbalance Between the Inhibition And Activamentioning
confidence: 99%